Value-based Care News and Resources for Healthcare

Controlling Oncology Costs with Cross-Benefit Drug Management

October 9, 2023 - The oncology care landscape is dynamic, shaped by rising cancer medication expenses, medical advancements, and the persistent influence of outside challenges like COVID-19. To navigate this complexity and its implications for future cancer care, cross-benefit drug management intervenes to tackle challenges and offer solutions. The Rising Tide...

CMS Proposes Delay of Medicaid Value-Based Payment Requirements

June 01, 2021 by Samantha McGrail

CMS recently proposed delaying Medicaid value-based drug payment requirements for state purchasing agreements with drug manufacturers until July 2022. The rule, called “Medicaid Program...

Exploring the Most Favored Nation Approach for Drug Pricing

September 25, 2020 by Samantha McGrail

According to the White House, this strategy would allow Americans to receive the same low prices for prescription medications that are available in other countries. But many stakeholders have...

Pharmaceutical M&A Activity Increased 17% in First Half of 2020

September 02, 2020 by Samantha McGrail

The COVID-19 pandemic has substantially shaped the pharmaceutical and biopharmaceutical industry over the first half of 2020, and while some of the activity was predictable, other trends have surprised...

Combination Antibody Therapy Reduces Relapsed Multiple Myeloma

June 09, 2020 by Samantha McGrail

Sanofi recently announced that when Sarclisa (isatuximab), a monoclonal antibody, is added to carfilozomib and dexamethasone, it reduces the risk of relapsed multiple myeloma progression or death in...

Cancer Clinical Trial Enrollment Fell During COVID-19 Pandemic

June 08, 2020 by Samantha McGrail

A recent study found that the COVID-19 pandemic is associated with a notable decrease in enrollment in National Cancer Institute-sponsored clinical trials for cancer treatments, especially in strongly...

Gilead Reports Remdesivir Helped Moderately Ill COVID-19 Patients

June 03, 2020 by Samantha McGrail

Gilead Sciences recently announced positive results from its Phase 3 SIMPLE clinical trial evaluating remdesivir as a COVID-19 drug for moderately ill COVID-19 patients. For more coronavirus updates,...

Antidepressant Ineffective Against Apathy in Alzheimer’s Patients

June 02, 2020 by Samantha McGrail

A recent analysis of a randomized clinical trial found that the antidepressant bupropion was not superior to a placebo for the treatment of apathy in patients with dementia of Alzheimer type (DAT)...

Robust Biosimilars Market Promotes High Savings, Affordability

June 01, 2020 by Samantha McGrail

US taxpayers and the healthcare sector may save nearly $7 billion annually with a stronger, more competitive biosimilars market, which is a significant increase from the current annual cost-savings of...

Obtaining Contraceptives from Pharmacists Boosts Continuous Adherence

May 29, 2020 by Samantha McGrail

Women who obtained direct contraceptive prescriptions from their pharmacist were able to minimize breaks in contraceptive coverage, while increasing their continuous adherence, according to researchers...

GSK Touts HIV Prevention Breakthrough with Long-Acting Injection

May 20, 2020 by Samantha McGrail

A global HIV prevention study found that the long-acting injection cabotegravir was 69 percent more effective than among key patient populations compared to the current standard of care, a daily oral...

CRISPR Technology Detects COVID-19 From Respiratory RNA Extracts

April 17, 2020 by Samantha McGrail

The lack of rapid and accurate molecular diagnostic testing has impeded the healthcare system’s response to the COVID-19 pandemic. Recently, researchers developed rapid, easy-to-implement, and...

COVID-19 Spurs Eli Lilly to Drop Insulin Costs to $35 a Month

April 13, 2020 by Samantha McGrail

Eli Lilly and Company recently launched a program allowing anyone with or without commercial insurance to fill their monthly prescription of Lilly insulin for $35, boosting patient access to insulin...

FDA Issues Guidance on Conducting Clinical Trials During COVID-19

April 01, 2020 by Samantha McGrail

FDA recently announced that it issued a guidance for industry, investigators, and institutional review boards conducting clinical trials during the COVID-19 pandemic. For more coronavirus updates,...

Cell and Gene Therapy Development Increased 20%, PhRMA Finds

March 13, 2020 by Samantha McGrail

There are 362 investigational cell and gene therapies currently in clinical development, a 20 percent increase from 2018, according to a recent report from Pharmaceutical Research and Manufacturers of...

Prescription Drug Costs Increased 3X Over the Past Decade

March 04, 2020 by Samantha McGrail

The net cost of prescription drugs rose over three times faster than the rate of inflation over the last decade, according to researchers from the University of Pittsburgh’s Health Policy...

More Articles